Symbols / ASND $231.05 -3.85% Ascendis Pharma A/S
ASND Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 14.27B | Enterprise Value | 14.44B | Income | -228.03M | Sales | 720.13M | Book/sh | -3.11 | Cash/sh | 10.04 |
| Dividend Yield | — | Payout | 0.00% | Employees | 1189 | IPO | — | P/E | — | Forward P/E | 25.57 |
| PEG | — | P/S | 19.82 | P/B | -74.19 | P/C | — | EV/EBITDA | -109.86 | EV/Sales | 20.05 |
| Quick Ratio | 0.72 | Current Ratio | 1.04 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -4.44 | EPS next Y | 9.04 |
| EPS Growth | — | Revenue Growth | 42.30% | Earnings | 2026-04-30 | ROA | -6.86% | ROE | — | ROIC | — |
| Gross Margin | 86.82% | Oper. Margin | 0.96% | Profit Margin | -31.67% | Shs Outstand | 61.78M | Shs Float | 60.92M | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | 250.74 | 52W Low | 150.89 | Beta | 0.48 | Avg Volume | 661.11K |
| Volume | 1.76M | Target Price | $339.76 | Recom | Buy | Prev Close | $240.29 | Price | $231.05 | Change | -3.85% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$47.99
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
No recent news from Yahoo. Try the RSS feed for latest ASND news.
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|